Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.11.16 extracted from

  • Tieku, S.; Hooper, M.
    Inhibition of aminopeptidases N, A, and W (1992), Biochem. Pharmacol., 44, 1725-1730.
    View publication on PubMed
Search for more literature for 3.4.11.16

Application

Application Comment Organism
medicine chemotherapeutic target, involved in heart disease, metastasis, inflammation Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
amastatin 100% inhibition at 0.1 mM Sus scrofa
arphamenine A 50% inhibition at 0.1 mM Sus scrofa
Arphamenine B 7% inhibition at 0.1 mM Sus scrofa
bestatin some of the observed chemotherapeutic actions of bestatin may be due to inhibition of enzyme Homo sapiens
bestatin 89% inhibition at 0.1 mM Sus scrofa
captopril 56% inhibition at 0.1 mM Sus scrofa
cilazaprilat 27% inhibition at 0.1 mM Sus scrofa
lisinopril 28% inhibition at 0.1 mM Sus scrofa
pentoprilat 27% inhibition at 0.1 mM Sus scrofa
probestin % inhibition at 0.1 mM Sus scrofa
rentiapril 100% inhibition at 0.1 mM Sus scrofa
spiraprilat 28% inhibition at 0.1 mM Sus scrofa
zofenoprilat 82% inhibition at 0.1 mM Sus scrofa

Localization

Localization Comment Organism GeneOntology No. Textmining

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-
Sus scrofa
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
kidney
-
 Sus scrofa
-